ViyaMD Inc. — SEC Form D Filing

ViyaMD Inc. filed an SEC Form D on July 6, 2026, reporting $5.00M raised in Healthcare Technology.

Form D filing details

Filing
SEC Form D
Filing date
July 6, 2026
Amount reported
$5.00M
Round stage
Seed
Industry
Healthcare Technology
Website
https://www.viyamd.com/

What the company does

Securities: Equity. Exemption: Rule 506(b). Incorporated: DELAWARE

Problem

Organizations like law firms, health systems, and insurers spend weeks manually organizing and analyzing vast amounts of complex medical records, often missing critical details or insights.

Solution

ViyaMD provides a Clinical Intelligence Platform that uses AI to automatically extract, organize, and analyze medical data, generating accurate medical chronologies and clinical insights from thousands of pages in minutes.

Why now

The proliferation of digital medical records combined with advancements in AI and natural language processing allows for efficient, automated analysis of previously unmanageable data volumes, addressing the growing need for rapid clinical insights in legal, insurance, and medical contexts.

Verdict

Investors backed ViyaMD on the bet that automating medical record analysis would unlock new efficiencies for incumbent services, rather than create a new market. This cleared because it offered a clear cost replacement for established, painful manual processes, not because it promised novel clinical outcomes. The upside was limited to market share capture in a known workflow, constrained by the slow adoption cycles inherent in highly regulated and risk-averse enterprise buyers.

Source: SEC EDGAR Form D filing